Our DNA
We are a different kind of venture capital firm.
With our hi-tech, hi-touch approach, we help to unlock value for the companies we invest in by accelerating their growth in domestic and international markets.
WIN77Our Thesis
We are investors in B2B and Enterprise
Technology opportunities with a significant India connection.
Built in India for the World
Cloud-based, enterprise-first digital companies being built in India as initial markets but applicable globally.
ESG-positive businesses
Fintech, Healthtech, Mobility, Cleantech and Agritech companies for aspirational India, and other international markets.
Emerging technologies
Backing companies and entrepreneurs in breakout areas (deep tech, space tech, web3, AR/VR etc.) for the next decade.
Our Approach
We pride ourselves in being the investor our portfolio founders value most on their cap table, with equal amounts of constructive challenge and unconditional support.
With our Morphosis 3/6 Acceleration Model © , we source and supercharge growth for the right investment opportunities
Learn MoreOur Technology
We are investing in proprietary technology that our portfolio companies can leverage to accelerate growth while also allowing our funds to source and screen investment opportunities more meaningfully.
Learn MoreOur Core Team
Our Portfolio
Our Perspectives
 (3).jpg)
Part 2: Preparing for a Regulated AI World
Narayanan Muralidharan
Dec 06,2023
Part 1: The ESG impact of Large Language Models, commonly known as Generative AI
Narayanan Muralidharan
Oct 04,2023
Venture Capital: An attractive asset class set to outperform
Kartik Chandra
Dec 11,2022
Why we are bullish on the India early-stage technology opportunity?
Kartik Chandra
Jan 15,2023
